Claudia M. Perez-Kasmarski

FDA investigator

Appears on 11 documents from 2020 to 2025, mostly at sites in California. Most often cites general requirements (21 CFR 211.160).

11
Documents on file
5.8
Observations per 483
2020
First seen
2025
Most recent

What they cite most

From 64 observations

Activity by year

2020: 1, 2021: 3, 2022: 3, 2024: 1, 2025: 3

Where

California 9 · India 2

Often inspects with

Lisa Shin· Eileen A. Liu· Navneet Kaur

Is Claudia M. Perez-Kasmarski coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

11 documents, newest first
FirmOpen
483 Sun Pharmaceutical Medicare Ltd.Sep 19, 2025 · Halol, India
483 Aurobindo Pharma Ltd.Sep 5, 2025 · Bachupallv, India
483 OASIS Medical, Inc.Jan 27, 2025 · Glendora, California
483 Pharmadepot Labs, LLCJun 18, 2024 · San Diego, California
483 FNC MEDICAL CORPORATIONDec 9, 2022 · VENTURA, California
483 COSMOCEUTICAL RESEARCH CENTER INCNov 4, 2022 · PANORAMA CITY, California
483 Green Wave Analytical, LLCMar 7, 2022 · San Diego, California

About this profile

What does Claudia M. Perez-Kasmarski inspect?

Claudia M. Perez-Kasmarski appears on 11 documents on file covering 11 sites, mostly in California.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.194 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Claudia M. Perez-Kasmarski is dated Sep 19, 2025.